Bowen Wan (Photo: LinkedIn) reduced her lamotrigine dose from 400 milligrams to zero over 25 days on ChatGPT’s guidance, according to the lawsuit. (Photo: iStock)
\n\nArtificial intelligence (AI) is increasingly making real life feel like an episode of Black Mirror. The family of a 31-year-old woman in Seattle is suing OpenAI, alleging that ChatGPT encouraged her to taper off her anti-seizure medication and helped her hide the plan from her doctors in the weeks before she died.
\n\nAccording to a New York Times report, the parents of Bowen Wan claim the chatbot guided her away from lamotrigine, the drug that controlled her severe epilepsy.
\n\nShe was laid off in November 2025 and began searching for a new job to keep her Green Card status. She was also worried that her epilepsy medication, lamotrigine, was affecting her ability to work. The lawsuit states that ChatGPT convinced her to wean herself off the drug.
\n\nThe Cleveland Clinic describes lamotrigine as a medication that treats epilepsy by preventing and controlling seizures. It can also treat bipolar disorder. Common brand names include Lamictal and Subvenite.
\n\nAccording to the lawsuit, the stakes for Wan were high. “Her green card now depended on finding a new…
Original source: https://www.timesnownews.com/lifestyle
